Prokarium's Unattributed VC Round

Prokarium raised a round of funding on February 26, 2018.

Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad …

Articles about Prokarium's Unattributed VC Round: